Health In Tech (NASDAQ:HIT) Rating Increased to Strong-Buy at Wall Street Zen

Health In Tech (NASDAQ:HIT) was upgraded by equities researchers at Wall Street Zen from a “buy” rating to a “strong-buy” rating in a report issued on Saturday.

Separately, Maxim Group raised Health In Tech to a “strong-buy” rating and set a $2.50 price target on the stock in a research report on Thursday, June 26th.

Health In Tech Stock Performance

Health In Tech stock opened at $1.84 on Friday. The business has a fifty day moving average of $0.86 and a two-hundred day moving average of $2.39. Health In Tech has a twelve month low of $0.51 and a twelve month high of $7.59.

Health In Tech (NASDAQ:HIT) last posted its earnings results on Monday, July 21st. The company reported $0.01 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.01. The company had revenue of $9.31 million for the quarter, compared to analysts’ expectations of $7.96 million.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the stock. Jane Street Group LLC purchased a new position in Health In Tech in the 1st quarter valued at about $48,000. Cubist Systematic Strategies LLC purchased a new position in Health In Tech in the 1st quarter valued at about $41,000. Arete Wealth Advisors LLC purchased a new position in Health In Tech in the 1st quarter worth approximately $47,000. Finally, XTX Topco Ltd purchased a new position in Health In Tech in the 1st quarter worth approximately $59,000.

Health In Tech Company Profile

Health in Tech, Inc engages in the provision of insurance technology platforms which offer a marketplace of processes in the healthcare industry. Its services include Stone Mountain Risk, eDIYBS, HI Card, HI Performance Network, and Ancillary Products. The company was founded by Tim Johnson in 2014 and is headquartered in Stuart, FL.